AAAAAA

   
Results: 1-20 |
Results: 20
EFFECTS OF ORAL AND INTRAVENOUS TERAZOSIN AND HEAD-UP TILT ON BLOOD-PRESSURE RESPONSES IN PATIENTS WITH HYPERTENSION
Authors: ACHARI R HOSMANE B LINNEN P CAVANAUGH J BAROLDI P COHEN A
Citation: R. Achari et al., EFFECTS OF ORAL AND INTRAVENOUS TERAZOSIN AND HEAD-UP TILT ON BLOOD-PRESSURE RESPONSES IN PATIENTS WITH HYPERTENSION, Journal of clinical pharmacology, 38(6), 1998, pp. 545-553
DEPAKOTE CR - BIOPHARMACEUTICAL AND PHARMACOKINETIC STUDIES OF A NEW FORMULATION FOR ONCE-DAILY DOSING
Authors: COLLINS SD CAVANAUGH J ELISSEOU M LAMM J SOMMERVILLE KW
Citation: Sd. Collins et al., DEPAKOTE CR - BIOPHARMACEUTICAL AND PHARMACOKINETIC STUDIES OF A NEW FORMULATION FOR ONCE-DAILY DOSING, Neurology, 50(4), 1998, pp. 64004-64004
PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND CLARITHROMYCIN
Authors: OUELLET D HSU A GRANNEMAN GR CARLSON G CAVANAUGH J GUENTHER H LEONARD JM
Citation: D. Ouellet et al., PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND CLARITHROMYCIN, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 355-362
THE EFFECT OF MULTIPLE DOSES OF RITONAVIR ON THE PHARMACOKINETICS OF RIFABUTIN
Authors: CATO A CAVANAUGH J SHI H HSU A LEONARD J GRANNEMAN R
Citation: A. Cato et al., THE EFFECT OF MULTIPLE DOSES OF RITONAVIR ON THE PHARMACOKINETICS OF RIFABUTIN, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 414-421
PLASTIC TANKS OFFER SOLUTIONS FOR ABOVEGROUND STORAGE - DESIGN IMPROVEMENTS MAKE THERMOPLASTICS A VIABLE ALTERNATIVE TO METALS AND FIBERGLASS
Authors: CAVANAUGH J
Citation: J. Cavanaugh, PLASTIC TANKS OFFER SOLUTIONS FOR ABOVEGROUND STORAGE - DESIGN IMPROVEMENTS MAKE THERMOPLASTICS A VIABLE ALTERNATIVE TO METALS AND FIBERGLASS, Chemical processing, 61(8), 1998, pp. 85
ARE PROPHYLACTIC ANTIBIOTICS REQUIRED FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY
Authors: ILLIG KA SCHMIDT E CAVANAUGH J KRUSCH D SAX HC
Citation: Ka. Illig et al., ARE PROPHYLACTIC ANTIBIOTICS REQUIRED FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY, Journal of the American College of Surgeons, 184(4), 1997, pp. 353-356
EVALUATION OF THE EFFECT OF FLUCONAZOLE ON THE PHARMACOKINETICS OF RITONAVIR
Authors: CATO A CAO GL HSU A CAVANAUGH J LEONARD J GRANNEMAN R
Citation: A. Cato et al., EVALUATION OF THE EFFECT OF FLUCONAZOLE ON THE PHARMACOKINETICS OF RITONAVIR, Drug metabolism and disposition, 25(9), 1997, pp. 1104-1106
ASSESSING BIAS IN THE PSYCHOLOGICAL SCREENING OF POLICE RECRUITS
Authors: DAWKINS M OSTROV E DAWKINS M CAVANAUGH J
Citation: M. Dawkins et al., ASSESSING BIAS IN THE PSYCHOLOGICAL SCREENING OF POLICE RECRUITS, Psychology, 34(1), 1997, pp. 15-21
AFFECTED SIB-PAIR ANALYSIS OF PERICENTRIC CHROMOSOME-16 MARKERS IN INFLAMMATORY BOWEL-DISEASE FAMILIES
Authors: CAVANAUGH J WILSON S SRAML M STANFORD P GORSKA M FOOTE S CALLEN D PAVLI P
Citation: J. Cavanaugh et al., AFFECTED SIB-PAIR ANALYSIS OF PERICENTRIC CHROMOSOME-16 MARKERS IN INFLAMMATORY BOWEL-DISEASE FAMILIES, Gastroenterology, 112(4), 1997, pp. 946-946
INFLAMMATORY BOWEL-DISEASE - GERMS OR GENES
Authors: PAVLI P CAVANAUGH J GRIMM M
Citation: P. Pavli et al., INFLAMMATORY BOWEL-DISEASE - GERMS OR GENES, Lancet, 347(9010), 1996, pp. 1198-1198
CLINICAL-PHARMACOLOGY AND FIRST-TIME-IN-MAN STUDIES - THE FDA LEVELS THE PLAYING FIELD
Authors: LUDERER J PIERGIES AA JORKASKY D SEDMAN A REELE S FROEHLICH J CAVANAUGH J STEINMAN GL
Citation: J. Luderer et al., CLINICAL-PHARMACOLOGY AND FIRST-TIME-IN-MAN STUDIES - THE FDA LEVELS THE PLAYING FIELD, Journal of clinical pharmacology, 36(3), 1996, pp. 187-188
ASSESSMENT OF THE PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION BETWEENTERAZOSIN AND FINASTERIDE
Authors: SAMARA EE HOSMANE B LOCKE C EASON C CAVANAUGH J GRANNEMAN GR
Citation: Ee. Samara et al., ASSESSMENT OF THE PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION BETWEENTERAZOSIN AND FINASTERIDE, Journal of clinical pharmacology, 36(12), 1996, pp. 1169-1178
AFFECTED SIB PAIR ANALYSIS OF IL1 RECEPTOR ANTAGONIST IN INFLAMMATORYBOWEL-DISEASE FAMILIES
Authors: CAVANAUGH J WILSON S KOHONENCORISH M PAVLI P
Citation: J. Cavanaugh et al., AFFECTED SIB PAIR ANALYSIS OF IL1 RECEPTOR ANTAGONIST IN INFLAMMATORYBOWEL-DISEASE FAMILIES, Gastroenterology, 110(4), 1996, pp. 880-880
ARE PROPHYLACTIC ANTIBIOTICS REQUIRED FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY
Authors: ILLIG KA SCHMIDT E CAVANAUGH J KRUSCH D SAX HC
Citation: Ka. Illig et al., ARE PROPHYLACTIC ANTIBIOTICS REQUIRED FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY, Gastroenterology, 110(4), 1996, pp. 1394-1394
EFFECTS OF DIVALPROEX SODIUM ON AMITRIPTYLINE AND NORTRIPTYLINE PHARMACOKINETICS
Authors: WONG SL CAVANAUGH J SHI H AWNI WM GRANNEMAN GR
Citation: Sl. Wong et al., EFFECTS OF DIVALPROEX SODIUM ON AMITRIPTYLINE AND NORTRIPTYLINE PHARMACOKINETICS, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 48-53
VIRAL SAFETY OF PASTEURIZED INTRAVENOUS IMMUNE GLOBULIN
Authors: CHANDRA S CAVANAUGH J YERRAM N BERGMAN GE FLANIGAN E
Citation: S. Chandra et al., VIRAL SAFETY OF PASTEURIZED INTRAVENOUS IMMUNE GLOBULIN, Blood, 88(10), 1996, pp. 3088-3088
LACK OF ADVERSE PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN TERAZOSIN AND FINASTERIDE
Authors: CAVANAUGH J SAMARA E EASON C ACHARI R HOSMANE B SCHNECK D
Citation: J. Cavanaugh et al., LACK OF ADVERSE PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN TERAZOSIN AND FINASTERIDE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 171-171
ELIMINATION OF NONLIPID ENVELOPED VIRUSES IN THE PREPARATION OF A MONOCLONAL-ANTIBODY PURIFIED AND PASTEURIZED FACTOR-VIII CONCENTRATE (MONOCLATE-P(R))
Authors: CHANDRA S CAVANAUGH J BARHAM R FELDMAN F
Citation: S. Chandra et al., ELIMINATION OF NONLIPID ENVELOPED VIRUSES IN THE PREPARATION OF A MONOCLONAL-ANTIBODY PURIFIED AND PASTEURIZED FACTOR-VIII CONCENTRATE (MONOCLATE-P(R)), Blood, 86(10), 1995, pp. 768-768
COMPUTERIZED DOCUMENTATION IN-HOME HEALTH
Authors: NOONE C CAVANAUGH J MCKILLIP C
Citation: C. Noone et al., COMPUTERIZED DOCUMENTATION IN-HOME HEALTH, The Journal of nursing administration, 25(1), 1995, pp. 67-69
LACK OF EFFECT OF FLUOXETINE ON THE PHARMACOKINETICS (PK) PHARMACODYNAMICS (PD) OF ESTAZOLAM
Authors: CAVANAUGH J SCHNECK D EASON C HANSEN M GUSTAVSON L
Citation: J. Cavanaugh et al., LACK OF EFFECT OF FLUOXETINE ON THE PHARMACOKINETICS (PK) PHARMACODYNAMICS (PD) OF ESTAZOLAM, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 141-141
Risultati: 1-20 |